Clinical Trial Update: A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating talazoparib with or without enzalutamide in men with prostate cancer who have previously received abiraterone acetate, and the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Talazoparib (talazoparib)

Snippet

Sponsor: Prostate Cancer Clinical Trials Consortium | Conditions: Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer) | Phase 2 | Status: RECRUITING